A new industry-supported study released for World AMR Awareness Week highlights widening gaps between falling antibiotic ...

The landscape of phosphodiesterase 3/4 (PDE3/4) inhibitors is experiencing a significant transformation in 2025, driven by ...

Specialty pharma company SERB Pharmaceuticals has revealed the appointment of Vignesh Rajah as its chief medical officer (CMO ...

Xiangxue Life Sciences has agreed a strategic partnership with Guangzhou-based Damien Vaccines to co-develop in vivo TCR-T ...

US pharma major Merck (NYSE: MRK) has reported positive topline data from the Phase II Cadence trial, testing Winrevair ...

US RNA interference (RNAi)specialist Arrowhead Pharmaceuticals, yesterday revealed that the US Food and Drug Administration ...

The US Food and Drug Administration (FDA) published the final guidance for industry, “Considerations for Waiver Requests for ...

The European Commission has granted conditional marketing authorization of Roche’s Lunsumio (mosunetuzumab) subcutaneous (SC) ...

Bayer (BAYN: DE) has opened its first China-based innovation center in Beijing’s E-Town BioPark, positioning the site as a launchpad for local biotechs aiming for global markets. The German pharma ...

Australia’s CSL has announced plans to expand its US presence over the next five years, resulting in approximately $1.5 ...

Spanish plasma-based medicines producer Grifols today announced that the US Food and Drug Administration (FDA) has approved ...

The US Food and Drug Administration today announced it has approved Danish biotech firm Genmab’s Epkinly (epcoritamab-bysp) ...